Liver Regeneration after Acetaminophen Hepatotoxicity: Mechanisms and Therapeutic Opportunities.


Journal

The American journal of pathology
ISSN: 1525-2191
Titre abrégé: Am J Pathol
Pays: United States
ID NLM: 0370502

Informations de publication

Date de publication:
04 2019
Historique:
received: 28 09 2018
revised: 11 12 2018
accepted: 17 12 2018
pubmed: 18 1 2019
medline: 28 12 2019
entrez: 18 1 2019
Statut: ppublish

Résumé

Acetaminophen (N-acetyl-para-aminophenol; APAP) overdose is the most common cause of acute liver failure in the Western world, with limited treatment opportunities. For years, research on APAP overdose has been focused on investigating the mechanisms of hepatotoxicity, with limited success in advancing therapeutic strategies. Acute liver injury after any insult, including APAP overdose, is followed by compensatory liver regeneration, which promotes recovery and is a crucial determinant of the final outcome. Liver regeneration after APAP-induced liver injury is dose dependent and impaired after severe APAP overdose. Although robust regenerative response is associated with spontaneous recovery and survival, impaired regeneration results in faster progression of injury and death after APAP overdose. APAP hepatotoxicity-induced liver regeneration involves a complex time- and dose-dependent interplay of several signaling mediators, including growth factors, cytokines, angiogenic factors, and other mitogenic pathways. Compared with the liver injury, which is established before most patients seek medical attention and has proved difficult to manipulate, liver regeneration can be potentially modulated even in late-stage APAP-induced acute liver failure. Despite recent efforts to study the mechanisms of liver regeneration after APAP-induced liver injury, more comprehensive research in this area is required, especially regarding factors that contribute to impaired regenerative response, to develop novel regenerative therapies for APAP-induced acute liver failure.

Identifiants

pubmed: 30653954
pii: S0002-9440(18)30845-9
doi: 10.1016/j.ajpath.2018.12.006
pmc: PMC6446224
pii:
doi:

Substances chimiques

Analgesics, Non-Narcotic 0
Acetaminophen 362O9ITL9D

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

719-729

Subventions

Organisme : NIGMS NIH HHS
ID : P30 GM118247
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK098414
Pays : United States

Informations de copyright

Copyright © 2019 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Références

Toxicol Sci. 2018 Apr 1;162(2):599-610
pubmed: 29325178
Sci Transl Med. 2018 Aug 15;10(454):
pubmed: 30111642
N Engl J Med. 2013 Dec 26;369(26):2525-34
pubmed: 24369077
Gene Expr. 2018 May 18;18(2):115-123
pubmed: 29540258
Am J Pathol. 2002 Jul;161(1):155-61
pubmed: 12107100
Drug Metab Rev. 2012 Feb;44(1):88-106
pubmed: 22229890
J Cell Physiol. 2007 Nov;213(2):286-300
pubmed: 17559071
Hepatology. 2000 Sep;32(3):514-22
pubmed: 10960443
Hepatology. 2017 Apr;65(4):1384-1392
pubmed: 27997988
Am J Pathol. 2018 Oct;188(10):2223-2235
pubmed: 30031724
Lab Invest. 2003 Feb;83(2):199-206
pubmed: 12594235
Arch Toxicol. 2007 Oct;81(10):729-41
pubmed: 17431590
Biochem Biophys Res Commun. 2003 Apr 25;304(1):207-12
pubmed: 12705907
J Hepatol. 1994 Jan;20(1):106-11
pubmed: 8201209
Toxicol Sci. 2003 Oct;75(2):458-67
pubmed: 12883092
Dig Liver Dis. 2018 Feb;50(2):175-180
pubmed: 28867475
Hepatology. 2016 Nov;64(5):1711-1724
pubmed: 27397846
Toxicol Pathol. 2005;33(1):41-51
pubmed: 15805055
Basic Clin Pharmacol Toxicol. 2005 Jul;97(1):8-14
pubmed: 15943753
Lab Invest. 2017 Mar;97(3):318-328
pubmed: 27991908
Hepatology. 2019 Apr;69(4):1702-1718
pubmed: 29888801
Acta Biochim Biophys Sin (Shanghai). 2011 Apr;43(4):307-15
pubmed: 21335335
Gastroenterology. 2001 Feb;120(3):749-62
pubmed: 11179248
J Clin Transl Hepatol. 2014 Sep;2(3):153-61
pubmed: 26355817
Cell Prolif. 2018 Jun;51(3):e12445
pubmed: 29504225
Hepatology. 1993 Mar;17(3):429-33
pubmed: 8444417
Am J Physiol Gastrointest Liver Physiol. 2008 Jul;295(1):G45-G53
pubmed: 18467506
Am J Pathol. 2017 Mar;187(3):543-552
pubmed: 28068511
Gene Expr. 2016;17(1):35-45
pubmed: 27125733
Pharmacoepidemiol Drug Saf. 2011 Aug;20(8):819-26
pubmed: 21294217
Hepatology. 2005 Jan;41(1):26-31
pubmed: 15690478
Toxicol Sci. 2011 Mar;120(1):218-29
pubmed: 21135413
Toxicol Appl Pharmacol. 2003 Sep 15;191(3):211-26
pubmed: 13678654
Toxicol Sci. 2017 Feb;155(2):363-378
pubmed: 28123000
Hepatology. 1999 Dec;30(6):1425-33
pubmed: 10573521
J Pharmacol Exp Ther. 2010 Jul;334(1):33-43
pubmed: 20363854
Am J Pathol. 2014 Nov;184(11):3013-25
pubmed: 25193591
Toxicol Appl Pharmacol. 2003 Dec 1;193(2):218-27
pubmed: 14644624
Hepatology. 2006 Aug;44(2):379-88
pubmed: 16871587
J Leukoc Biol. 2008 Dec;84(6):1410-21
pubmed: 18713872
J Hepatol. 2016 Jan;64(1):69-78
pubmed: 26325537
Am J Prev Med. 2011 Jun;40(6):585-92
pubmed: 21565648
J Pharmacol Exp Ther. 2003 Oct;307(1):67-73
pubmed: 12954812
Clin Liver Dis. 2007 Aug;11(3):525-48, vi
pubmed: 17723918
Crit Care. 2012 Jan 16;16(1):R9
pubmed: 22248080
J Hepatol. 2015 Apr;62(1 Suppl):S112-20
pubmed: 25920080
Am J Physiol Gastrointest Liver Physiol. 2006 Jul;291(1):G102-9
pubmed: 16565415
Toxicol Sci. 2003 Jun;73(2):220-34
pubmed: 12700423
Hepatology. 2005 Jun;41(6):1252-61
pubmed: 15880565
Gastroenterology. 1995 Dec;109(6):1907-16
pubmed: 7498656
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17081-6
pubmed: 17940036
BMC Gastroenterol. 2011 Nov 15;11:125
pubmed: 22085740
Acad Emerg Med. 1999 Nov;6(11):1115-20
pubmed: 10569383
Crit Care. 2009;13(3):144
pubmed: 19490595
Am J Pathol. 2018 Jun;188(6):1406-1418
pubmed: 29654721
BMC Gastroenterol. 2012 May 08;12:45
pubmed: 22569100
Cell Death Dis. 2017 Oct 5;8(10):e3083
pubmed: 28981086
Crit Care. 2009;13(2):R55
pubmed: 19358737
Biochem Biophys Res Commun. 2003 Oct 3;309(4):857-63
pubmed: 13679052
Hepatology. 2002 May;35(5):1093-103
pubmed: 11981759
Am J Pathol. 2009 Sep;175(3):1056-65
pubmed: 19679878
Gut. 2018 Feb;67(2):333-347
pubmed: 28450389
Am J Pathol. 2013 Nov;183(5):1518-1526
pubmed: 24007882
Hepatology. 2012 Aug;56(2):735-46
pubmed: 22334567

Auteurs

Bharat Bhushan (B)

Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.

Udayan Apte (U)

Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas. Electronic address: uapte@kumc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH